Phase III Trial for Patients With mCSCC Who Progress After First-line Chemotherapy
November 19th 2018Danny Rischin, MD, MBBS, FRACP, discusses an ongoing phase III trial for patients with metastatic cutaneous squamous cell carcinoma or recurrent disease after progressing on frontline chemotherapy.